Fatemeh Fashami-Mirzayeh - Publications

Effectiveness and tolerability of pharmacological prophylaxis for migraine headaches: a systematic review and network meta-analysis of randomised controlled trials.

Journal: BMJ evidence-based medicine

Published: May 03, 2026

The cost-effectiveness of biosimilar denosumab in postmenopausal osteoporosis: implications of baseline fracture risk and drug price.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: March 22, 2026

Antibiotic Prophylaxis Strategies and Surgical Site Infections in Colorectal Surgery: A Systematic Review and Network Meta-Analysis.

Journal: JAMA network open

Published: February 19, 2026

Health technology assessment reports for oncology medications in Canada from 2018 to 2025: methodological critiques on manufacturers' submissions and a comparison between manufacturers and Canada's Drug Agency (CDA) analyses.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: February 12, 2026

Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis.

Journal: PharmacoEconomics - open

Published: October 02, 2025

Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses.

Journal: PharmacoEconomics - open

Published: September 17, 2024

Management of Amphetamine and Methamphetamine Use Disorders: A Systematic Review and Network Meta-analysis of Randomized Trials.

Journal: International journal of mental health and addiction

Published: August 19, 2024

Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses.

Journal: PharmacoEconomics - open

Published: July 03, 2024

A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: January 29, 2024

Olaparib versus Placebo in Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer: A Cost-Utility Analysis from the Canadian Public Payer's Perspective.

Journal: Current oncology (Toronto, Ont.)

Published: March 03, 2023

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis.

Journal: Iranian journal of pharmaceutical research : IJPR

Published: September 19, 2019